Skip to content
LS-CLS
Tissue
Hematopoietic
Disease
Lymphosarcoma

Documents

LS-CLS

Cell line · Product number 603390

The LS-CLS cell line was established from the primary lymphosarcoma of an adult Mesocricetus auratus (hamster). This cell line originates from the hematop...

US$395.00excl. tax and shipping
Made to order
1

01General information

Description

The LS-CLS cell line was established from the primary lymphosarcoma of an adult Mesocricetus auratus (hamster). This cell line originates from the hematopoietic lineage, specifically representing a lymphosarcoma, which is a type of cancer that affects lymphocytes, key components of the immune system. Lymphosarcomas are typically malignant, rapidly proliferating, and capable of metastasizing to various organs, making them significant in studies related to cancer biology, particularly hematologic malignancies.

As an in vitro model, the LS-CLS cell line is valuable for researching the mechanisms of lymphosarcoma development and progression. It can also be used to investigate potential therapeutic approaches, including chemotherapeutic agents and targeted therapies aimed at hematopoietic cancers.

Tissue
Hematopoietic
Disease
Lymphosarcoma

02Classification

Organism
Golden hamster
Sex
Unspecified
Growth properties
Suspension
Biosafety level
1

03Characteristics

Morphology
Round cells

04Identifiers

Citation
LS-CLS (Cytion catalog number 603390)
NCBI TaxID
10036
Cellosaurus
CVCL_5789

05Handling and culture

Culture medium
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Subculturing
Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth.
Seeding density
1 to 2 x 106 cells/ml
Fluid renewal
Every 3 to 5 days
Post-thaw recovery
24 to 48 hours
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

06Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

07Donor

Donor age
Adult